SCHEME 1
A Con ven ien t On e-P ot Syn th esis of
1,8-Na p h th yr id on es
Shawn A. Springfield,* Karen Marcantonio,
Scott Ceglia, J ennifer Albaneze-Walker,
Peter G. Dormer, Todd D. Nelson, and J erry A. Murry
SCHEME 2
Department of Process Research, Merck & Co. Inc.,
P.O. Box 2000, Rahway, New J ersey 07065-0900
shawn_springfield@merck.com
Received March 11, 2003
Abstr a ct: In this paper, we disclose an efficient one-pot
procedure for the preparation of substituted 1,8-naphthyri-
din-4-one analogues. Previous efforts to effect this type of
transformation were complicated by the formation of ben-
zene tricarboxylate. Via the use of excess base, the impurity
formation was completely inhibited. This allowed for the
clean preparation of the desired intermediate and subse-
quent formation of naphthyridone analogues in a single
flask, which could then be crystallized directly from the
reaction mixture in good yield and high purity.
that involves the condensation of 2-chloronicotinoyl
chloride with ethyl-3,3-dimethylaminoacrylate followed
by in situ reaction with a variety of anilines to provide
the desired 1,8-naphthyridone in a single flask.
We recently required a facile method for the prepara-
tion of 1,8-naphthyridone analogues on a large scale.
While the existing methodology allowed access to a
variety of these compounds, they suffered from high
temperatures and or messy reaction mixtures that re-
quired tedious purification and were not immediately
amenable to multi-kilogram scale. We envisioned a one-
pot process that would allow for a convenient way of
varying substitution, while providing pure material in
good yield by direct crystallization of the product from
the crude reaction mixture.
Our initial experiments involved heating 2-chloroni-
cotinoyl chloride with dimethylamino acrylate in aceto-
nitrile to provide the desired intermediate (2).10 These
reactions were complicated by the excessive formation
of the corresponding triethyl 1,3,5-benzenetricarboxylate
from trimerization of the acrylate (Scheme 1). We rea-
soned that this reaction was acid catalyzed and investi-
gated the effect of base on the yield of the proposed
reaction. It was found that the amount of trimer was
inversely proportional to the amount of base. By taking
advantage of this observation and using 4 equiv of base,
the trimerization was completely inhibited in acetonitrile
and the 3,3-(dimethylamino)-2-[2-chloronicotinyl]acrylic
acid ethyl ester intermediate (2) was formed in high
purity without the need to isolate. This allowed for the
1,8-Naphthyridin-4-ones are a group of heterocycles
that demonstrate biological activity toward numerous
important targets. As a result there are many recent
examples of preparing these compounds.1
Most of the documented chemistry for the formation
of this particular class of naphthyridones utilizes one of
two common approaches toward their synthesis. The first
method involves the preparation of an alkyl 1-substituted-
2-[2-substituted nicotinyl]acrylic acid ethyl ester inter-
mediate (2), followed by base-catalyzed ring closure to
form the desired naphthyridone. Of the several ways of
preparing this intermediate many are labor intensive.
They require the formation of a 2-substituted pyridinyl
acetate typically prepared via malonic ester acylation
with 2-chloronicotinoyl chloride, followed by decarboxy-
lation and then subsequent reaction with either di-
methylamino dimethyl acetal, triethylorthoformate/acetic
anhydride, or an iminochlorothioformate.2-6 A second
option is to employ the use of a thermal rearrangement/
cyclization that requires temperatures as high as 350
°C.7-9 In this paper, we disclose a new, one-pot method
(1) For a review, see: Stanforth, S. P. Comprehensive Heterocyclic
Chemistry II; Elsevier Science Ltd.: New York, 1996; pp 527-559.
(2) J acquet, J .-P.; Bouzard, D.; Di Cesare, P.; Dolnic, N.; Massoudi,
M.; Remuzon, P. Heterocycles 1992, 34 (12), 2301.
(3) Bouzard, D.; Di Cesare, P.; Essiz, M.; J acquet, J . P.; Ledoussal,
B.; Remuzon, P.; Kessler, R. E.; Fung-Tomc, J . J . Med. Chem. 1992,
35, 518.
(4) Chu, D. T. W.; Fernandes, P. B.; Claiborne, A. K.; Gracey, E.
H.; Pernet, A. G. J . Med. Chem. 1986, 29, 2363.
(5) Yoon, S. J .; Chung, Y. H.; Lee, C. W.; Oh, Y. S.; Choi, D. R.;
Kim, N. D.; Lim, J . K.; J in, Y. H.; Lee, D. K.; Lee, W. Y. J . Heterocycl.
Chem. 1997, 34, 1021.
(6) Chu, D. T. W.; Claiborne, A. K. J . Heterocycl. Chem. 1990, 27,
1191.
(7) Hermecz, I.; Horvath, A. J . Heterocycl. Chem. 1992, 29, 559.
(8) Chen, K.; Kuo, S.-C.; Hsieh, M.-C.; Mauger, A.; Lin, C. M.;
Hamel, E.; Lee, K.-H. J . Med. Chem. 1997, 40, 2266.
(9) Hirose, T.; Mishio, S.; Matsumoto, J .-I.; Minami, S. Chem.
Pharm. Bull. 1982, 30, 2399.
(10) Chemistry involving the use of 3,3-dimethylaminoacrylate to
form a 2-benzoylacrylic carboxylate was demonstrated in the follow-
ing: Grohe, K. U.S. Patent 2 699 992, 1987. Bose, P.; Kumar, N.;
Kiyoto, T. W.O. Patent 01 66512 A1, 2001. Neither utilized this
chemistry for preparing 1,8-naphthyridin-4-ones.
(11) HPLC samples were quenched with n-propylamine, and con-
sumption of starting material was considered complete when less than
3 liquid chromatography area percent n-propyl-2-chloronicotinamide
was detected.
10.1021/jo034321f CCC: $25.00 © 2003 American Chemical Society
Published on Web 05/07/2003
4598
J . Org. Chem. 2003, 68, 4598-4599